18-45865765-CAAAAAAA-CAAAAAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_020964.3(EPG5):​c.6622-7delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.193 in 102,434 control chromosomes in the GnomAD database, including 1,636 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 1636 hom., cov: 25)
Exomes 𝑓: 0.33 ( 184 hom. )
Failed GnomAD Quality Control

Consequence

EPG5
NM_020964.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.327

Publications

3 publications found
Variant links:
Genes affected
EPG5 (HGNC:29331): (ectopic P-granules 5 autophagy tethering factor) This gene encodes a large coiled coil domain-containing protein that functions in autophagy during starvation conditions. Mutations in this gene cause Vici syndrome. [provided by RefSeq, Aug 2015]
EPG5 Gene-Disease associations (from GenCC):
  • Vici syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 18-45865765-CA-C is Benign according to our data. Variant chr18-45865765-CA-C is described in ClinVar as Benign. ClinVar VariationId is 402832.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPG5NM_020964.3 linkc.6622-7delT splice_region_variant, intron_variant Intron 38 of 43 ENST00000282041.11 NP_066015.2 Q9HCE0-1Q9BTI0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPG5ENST00000282041.11 linkc.6622-7delT splice_region_variant, intron_variant Intron 38 of 43 1 NM_020964.3 ENSP00000282041.4 Q9HCE0-1

Frequencies

GnomAD3 genomes
AF:
0.193
AC:
19781
AN:
102424
Hom.:
1634
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.0983
Gnomad AMR
AF:
0.361
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.400
Gnomad SAS
AF:
0.342
Gnomad FIN
AF:
0.224
Gnomad MID
AF:
0.189
Gnomad NFE
AF:
0.157
Gnomad OTH
AF:
0.198
GnomAD2 exomes
AF:
0.371
AC:
38881
AN:
104766
AF XY:
0.367
show subpopulations
Gnomad AFR exome
AF:
0.356
Gnomad AMR exome
AF:
0.392
Gnomad ASJ exome
AF:
0.367
Gnomad EAS exome
AF:
0.386
Gnomad FIN exome
AF:
0.366
Gnomad NFE exome
AF:
0.366
Gnomad OTH exome
AF:
0.369
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.329
AC:
378011
AN:
1150714
Hom.:
184
Cov.:
0
AF XY:
0.328
AC XY:
186861
AN XY:
569160
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.319
AC:
7804
AN:
24492
American (AMR)
AF:
0.358
AC:
10024
AN:
27996
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
6320
AN:
18448
East Asian (EAS)
AF:
0.408
AC:
13944
AN:
34208
South Asian (SAS)
AF:
0.340
AC:
21212
AN:
62396
European-Finnish (FIN)
AF:
0.338
AC:
11575
AN:
34220
Middle Eastern (MID)
AF:
0.349
AC:
1335
AN:
3828
European-Non Finnish (NFE)
AF:
0.323
AC:
289380
AN:
896776
Other (OTH)
AF:
0.340
AC:
16417
AN:
48350
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.332
Heterozygous variant carriers
0
20523
41046
61570
82093
102616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11334
22668
34002
45336
56670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.193
AC:
19779
AN:
102434
Hom.:
1636
Cov.:
25
AF XY:
0.205
AC XY:
10072
AN XY:
49228
show subpopulations
African (AFR)
AF:
0.127
AC:
3210
AN:
25188
American (AMR)
AF:
0.361
AC:
4106
AN:
11360
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
404
AN:
2382
East Asian (EAS)
AF:
0.399
AC:
1590
AN:
3980
South Asian (SAS)
AF:
0.343
AC:
1241
AN:
3620
European-Finnish (FIN)
AF:
0.224
AC:
1393
AN:
6230
Middle Eastern (MID)
AF:
0.182
AC:
28
AN:
154
European-Non Finnish (NFE)
AF:
0.157
AC:
7464
AN:
47488
Other (OTH)
AF:
0.198
AC:
285
AN:
1442
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
718
1436
2153
2871
3589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0344
Hom.:
20

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 39% of patients studied by a panel of primary immunodeficiencies. Number of patients: 37. Only high quality variants are reported. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - No homozygotes in ExAC -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Vici syndrome Benign:2
Jan 12, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11333207; hg19: chr18-43445730; COSMIC: COSV56349940; API